Trial Protocol ID USOR 22041_M23-362

Trial Description

A Phase 2, Open-Label Trial to Evaluate Safety of Epcoritamab Monotherapy in Subjects with Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma Grade 1-3a when Administered in the Outpatient Setting

Contact us regarding Clinical Trials at or call us at 877-664-7724


  • Syed Shahid Mahmood, M.D.

Disease Types


  • AbbVie NCT ID

  • NCT05451810